<VariationArchive VariationID="7380" VariationName="NM_004357.5(CD151):c.382dup (p.Asp128fs)" VariationType="Duplication" Accession="VCV000007380" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-01-26" DateCreated="2021-11-05" MostRecentSubmission="2021-11-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22419" VariationID="7380">
      <GeneList>
        <Gene Symbol="CD151" FullName="CD151 molecule (Raph blood group)" GeneID="977" HGNC_ID="HGNC:1630" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.5</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="832952" stop="838831" display_start="832952" display_stop="838831" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="832951" stop="838834" display_start="832951" display_stop="838834" Strand="+" />
          </Location>
          <OMIM>602243</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004357.5(CD151):c.382dup (p.Asp128fs)</Name>
      <CanonicalSPDI>NC_000011.10:837278:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11p15.5</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="837278" stop="837279" display_start="837278" display_stop="837279" variantLength="1" positionVCF="837278" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="837278" stop="837279" display_start="837278" display_stop="837279" variantLength="1" positionVCF="837278" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>D128fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004357.4" sequenceAccession="NM_004357" sequenceVersion="4" change="c.382dupG">
            <Expression>NM_004357.4:c.382dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.837280dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.837280dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.837280dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.837280dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007478.1" sequenceAccession="NG_007478" sequenceVersion="1" change="g.9329dup">
            <Expression>NG_007478.1:g.9329dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001039490.2" sequenceAccession="NM_001039490" sequenceVersion="2" change="c.382dup">
            <Expression>NM_001039490.2:c.382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001034579.1" sequenceAccession="NP_001034579" sequenceVersion="1" change="p.Asp128fs">
            <Expression>NP_001034579.1:p.Asp128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004357.5" sequenceAccession="NM_004357" sequenceVersion="5" change="c.382dup" MANESelect="true">
            <Expression>NM_004357.5:c.382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004348.2" sequenceAccession="NP_004348" sequenceVersion="2" change="p.Asp128fs">
            <Expression>NP_004348.2:p.Asp128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139029.2" sequenceAccession="NM_139029" sequenceVersion="2" change="c.382dup">
            <Expression>NM_139029.2:c.382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_620598.1" sequenceAccession="NP_620598" sequenceVersion="1" change="p.Asp128fs">
            <Expression>NP_620598.1:p.Asp128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139030.4" sequenceAccession="NM_139030" sequenceVersion="4" change="c.382dup">
            <Expression>NM_139030.4:c.382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_620599.1" sequenceAccession="NP_620599" sequenceVersion="1" change="p.Asp128fs">
            <Expression>NP_620599.1:p.Asp128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_817" sequenceAccession="LRG_817">
            <Expression>LRG_817:g.9329dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_817t1" sequenceAccession="LRG_817t1">
            <Expression>LRG_817t1:c.382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_817p1" sequenceAccession="LRG_817p1" change="p.Asp128fs">
            <Expression>LRG_817p1:p.Asp128fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="602243.0001" DB="OMIM" />
        <XRef Type="rs" ID="1565118389" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004357.5(CD151):c.382dup (p.Asp128fs) AND Epidermolysis bullosa simplex 7, with nephropathy and deafness" Accession="RCV000007805" Version="4">
        <ClassifiedConditionList TraitSetID="2009">
          <ClassifiedCondition DB="MedGen" ID="C1836823">Epidermolysis bullosa simplex 7, with nephropathy and deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-10-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-10-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-11-05" MostRecentSubmission="2021-11-05">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15265795</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2009" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3447" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nephropathy with pretibial epidermolysis bullosa and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephrotic syndrome - deafness - pretibial epidermolysis bullosa syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex 7, with nephropathy and deafness</ElementValue>
                <XRef ID="MONDO:0012190" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.</Attribute>
                <XRef ID="NBK1369" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17367" />
                <XRef ID="17367" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301543</ID>
                <ID Source="BookShelf">NBK1369</ID>
              </Citation>
              <XRef ID="300333" DB="Orphanet" />
              <XRef ID="C1836823" DB="MedGen" />
              <XRef ID="MONDO:0012190" DB="MONDO" />
              <XRef Type="MIM" ID="609057" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28006" SubmissionDate="2021-10-29" DateLastUpdated="2021-11-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602243.0001_EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS" title="CD151, 1-BP INS, 383G_EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS" />
        <ClinVarAccession Accession="SCV000028006" DateUpdated="2021-11-05" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-10-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 MER2-negative patients of Indian Jewish origin with epidermolysis bullosa simplex and end-stage kidney disease (EBS7; 609057), Karamatic Crew et al. (2004) found homozygosity for a single-nucleotide insertion (383_384insG) in exon 5 of the CD151 gene, causing a frameshift and premature stop signal in codon 140. The resultant truncated protein would lack its integrin-binding domain. The findings suggested that CD151 is essential for the proper assembly of the glomerular and tubular basement membrane in kidney, as well as having functional significance in skin and probably the inner ear.</Attribute>
              <Citation>
                <ID Source="PubMed">15265795</ID>
              </Citation>
              <XRef DB="OMIM" ID="609057" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CD151" />
          </GeneList>
          <Name>CD151, 1-BP INS, 383G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 383G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602243.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="28006" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS" MappingRef="Preferred">
        <MedGen CUI="C1836823" Name="Epidermolysis bullosa simplex 7, with nephropathy and deafness" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

